AI Science Tracker
EN

Machine learning identifies candidate sepsis molecular subtypes and associated markers

Chengdu University of Traditional Chinese Medicine; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China · 17 Nov 2026 · medicine

Discovery

Machine learning identifies candidate sepsis molecular subtypes and associated markers

Source check: Source checked. Not independent scientific confirmation.

Finding: Transcriptomic clustering and machine-learning feature selection identified three candidate sepsis groups with differing observed 28-day outcomes and a four-gene classifier. A separate dataset and cell experiments provide exploratory checks. The authors caution that these groups are not established clinical phenotypes and need prospective validation.

Technology: Nonnegative-matrix-factorization clustering defined transcriptomic groups; feature-selection methods and an SVM identified and classified subtype-associated markers.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Nonnegative-matrix-factorization clustering defined transcriptomic groups; feature-selection methods and an SVM identified and classified subtype-associated markers.
Test and result
The classifier was assessed in a separate transcriptomic cohort; exploratory cell work examined one marker.
Limitation / still unknown
Subtype labels are not established clinical phenotypes; analysis and cell follow-up do not demonstrate clinical utility or treatment efficacy.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13778446/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.